Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rahul S. Tade, Mahesh P. More, Sopan N. Nangare & Pravin O. Patil. (2022) Graphene quantum dots (GQDs) nanoarchitectonics for theranostic application in lung cancer. Journal of Drug Targeting 30:3, pages 269-286.
Read now
Read now
Articles from other publishers (40)
Mo Chen. (2023) A Comparative Study of Transfer Learning based Models for Lung Cancer Histopathology Classification. Highlights in Science, Engineering and Technology 39, pages 26-34.
Crossref
Crossref
Jingting Wang, Feiyang Zhong, Feng Xiao, Xinyang Dong, Yun Long, Tian Gan, Ting Li & Meiyan Liao. (2023) CT radiomics model combined with clinical and radiographic features for discriminating peripheral small cell lung cancer from peripheral lung adenocarcinoma. Frontiers in Oncology 13.
Crossref
Crossref
尚莹 孙. (2023) Clinical Features, Molecular Features and Prognosis of Lung Adeno-Squamous Cell Car-cinoma. Advances in Clinical Medicine 13:02, pages 1770-1776.
Crossref
Crossref
Shabir Ahmad Ganai, Basit Amin Shah & Manzoor Ahmad Yatoo. 2023. Epigenetic Regulation of Cancer in Response to Chemotherapy. Epigenetic Regulation of Cancer in Response to Chemotherapy
163
198
.
Chao-Yuan Chang, Yung-Chi Huang, Hung-Hsing Chiang, Yu-Yuan Wu, Kuan-Li Wu, Yung-Yun Chang, Lian-Xiu Liu, Ying-Ming Tsai & Ya-Ling Hsu. (2022) Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing Invasiveness in Lung Adenocarcinoma. International Journal of Molecular Sciences 24:1, pages 431.
Crossref
Crossref
Neel Desai, Jeffrey S. Morris & Veerabhadran Baladandayuthapani. (2022) NetCellMatch: Multiscale Network‐Based Matching of Cancer Cell Lines to Patients Using Graphical Wavelets. Chemistry & Biodiversity 19:12.
Crossref
Crossref
Maksat Babayev & Patricia Silveyra. 2022. Recent Advances in Noncoding RNAs. Recent Advances in Noncoding RNAs.
Hongbiao Wang, Jun Liu, Sujuan Zhu, Kun Miao, Zhifeng Li, Xiaofang Qi, Lujia Huang, Lijie Guo, Yan Wang, Yuyin Cai & Yingcheng Lin. (2022) Comprehensive analyses of genomic features and mutational signatures in adenosquamous carcinoma of the lung. Frontiers in Oncology 12.
Crossref
Crossref
Chao Li, Xiaobin Zheng, Pansong Li, Huijuan Wang, Jie Hu, Lin Wu, Zhijie Wang, Hui Guo, Fang Wu, Wenzhao Zhong, Chengzhi Zhou, Qian Chu, Jun Zhao, Xinlong Zheng, Weijin Xiao, Weifeng Zhu, Longfeng Zhang, Qian Li, Kan Jiang, Qian Miao, Biao Wu, Yiquan Xu, Shiwen Wu, Haibo Wang, Shanshan Yang, Yujing Li, Xuefeng Xia, Xin Yi, Cheng Huang, Bo Zhu & Gen Lin. (2022) Heterogeneity of tumor immune microenvironment and real-world analysis of immunotherapy efficacy in lung adenosquamous carcinoma. Frontiers in Immunology 13.
Crossref
Crossref
Daojuan Li, Jin Shi, Xiaoping Dong, Di Liang, Jing Jin & Yutong He. (2022) Epidemiological characteristics and risk factors of lung adenocarcinoma: A retrospective observational study from North China. Frontiers in Oncology 12.
Crossref
Crossref
Chuang Cheng, Zan Luo, Wei Xiong, Zhongquan Shi & Hui Tan. (2022) Epidemiology and survival outcomes in adenosquamous carcinoma: a population-based study. International Journal of Colorectal Disease 37:7, pages 1581-1592.
Crossref
Crossref
Zilai Wang, Jiyeon Kim, Pin Zhang, Jazmin M. Galvan Achi, Yuwei Jiang & Lijun Rong. (2022) Current therapy and development of therapeutic agents for lung cancer. Cell Insight 1:2, pages 100015.
Crossref
Crossref
James J. Saller & Theresa A. Boyle. (2022) Molecular Pathology of Lung Cancer. Cold Spring Harbor Perspectives in Medicine 12:3, pages a037812.
Crossref
Crossref
Ying Wu, Pei-Zhen Zhu, Yin-Qiao Chen, Jie Chen, Lu Xu & Huayi Zhang. (2022) Relationship between marital status and survival in patients with lung adenocarcinoma. Medicine 101:1, pages e28492.
Crossref
Crossref
Sara Manglaviti, Marta Brambilla, Diego Signorelli, Roberto Ferrara, Giuseppe Lo Russo, Claudia Proto, Giulia Galli, Alessandro De Toma, Mario Occhipinti, Giuseppe Viscardi, Teresa Beninato, Emma Zattarin, Marta Bini, Riccardo Lobefaro, Giacomo Massa, Achille Bottiglieri, Giulia Apollonio, Elisa Sottotetti, Rosa Maria Di Mauro, Benedetta Trevisan, Monica Ganzinelli, Alessandra Fabbri, Filippo G.M. de Braud, Marina Chiara Garassino & Arsela Prelaj. (2022) Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology. Clinical Lung Cancer 23:1, pages e17-e28.
Crossref
Crossref
Betul Gundogdu, Duygu Gurel & Emine Cagnur Ulukus. 2022. Biomarkers in Carcinoma of Unknown Primary. Biomarkers in Carcinoma of Unknown Primary
99
128
.
Hani Z. Asfour, Usama A. Fahmy, Waleed S. Alharbi, Alshaimaa M. Almehmady, Abdulmohsin J. Alamoudi, Singkome Tima, Rasha A. Mansouri, Ulfat M. Omar, Osama A. A. Ahmed, Shadi A. Zakai, Ahmed A. Aldarmahi, Alaa Bagalagel, Reem Diri & Nabil A. Alhakamy. (2021) Phyto-Phospholipid Conjugated Scorpion Venom Nanovesicles as Promising Carrier That Improves Efficacy of Thymoquinone against Adenocarcinoma Human Alveolar Basal Epithelial Cells. Pharmaceutics 13:12, pages 2144.
Crossref
Crossref
Ming Tang, Hussein A. Abbas, Marcelo V. Negrao, Maheshwari Ramineni, Xin Hu, Shawna Marie Hubert, Junya Fujimoto, Alexandre Reuben, Susan Varghese, Jianhua Zhang, Jun Li, Chi-Wan Chow, Xizeng Mao, Xingzhi Song, Won-Chul Lee, Jia Wu, Latasha Little, Curtis Gumbs, Carmen Behrens, Cesar Moran, Annikka Weissferdt, J. Jack Lee, Boris Sepesi, Stephen Swisher, Chao Cheng, Jonathan Kurie, Don Gibbons, John V. Heymach, Ignacio I. Wistuba, P. Andrew Futreal, Neda Kalhor & Jianjun Zhang. (2021) The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics. Nature Communications 12:1.
Crossref
Crossref
Hideto Oshita, Tatsuki Takahashi, Misato Senoo, Kunihiko Funaishi, Makoto Fujiwara, Yasuyuki Mitama & Ken Okusaki. (2021) A Case of Squamous Cell Carcinoma with Foci of Adenocarcinoma with Confirmed Metastatic Recurrence of the Adenocarcinoma Component腺癌成分の術後転移再発を確認しえた腺癌成分を含む肺扁平上皮癌の1例. Haigan 61:5, pages 402-406.
Crossref
Crossref
Cristian Prieto-Garcia, Ines Tomašković, Varun Jayeshkumar Shah, Ivan Dikic & Markus Diefenbacher. (2021) USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma. Cells 10:10, pages 2652.
Crossref
Crossref
Mehdi Djekidel, Ghulam Syed & Aladdin Kanbour. (2021)
Imaging Biomarkers in Lung Cancer with
68
Ga-DOTATATE,
18
F-Fluoride, and
18
F-FDG PET/CT Scans and the Theranostics Paradigm
. Journal of Nuclear Medicine Technology 49:3, pages 281-283.
Crossref
Crossref
Cheng Xu, Zhangyuan Gu, Juan Liu, Xiaoyan Lin, Cheng Wang, Jiejing Li, Yun Fu, Xiaolin Cheng & Zhigang Zhuang. (2021) Adenosquamous carcinoma of the breast: a population-based study. Breast Cancer 28:4, pages 848-858.
Crossref
Crossref
Cai-Bao Jin & Ling Yang. (2021) Histological transformation of non-small cell lung cancer: Clinical analysis of nine cases. World Journal of Clinical Cases 9:18, pages 4617-4626.
Crossref
Crossref
Shuai Kong, Lu Ding, Chenkun Fan, Yun Li, Chi Wang, Ke Wang, Weilong Xu, Xuanming Shi, Quan Wu & Fengsong Wang. (2021) Global analysis of lysine acetylome reveals the potential role of CCL18 in non‐small cell lung cancer. PROTEOMICS 21:7-8, pages 2000144.
Crossref
Crossref
Yong Cheng, Yanxiang Zhang, Yuwei Yuan, Jiao Wang, Ke Liu, Bin Yu, Li Xie, Chao Ou-Yang, Lin Wu & Xiaoqun Ye. (2021) The Comprehensive Analyses of Genomic Variations and Assessment of TMB and PD-L1 Expression in Chinese Lung Adenosquamous Carcinoma. Frontiers in Genetics 11.
Crossref
Crossref
Long Chen, Yue Liu, Jiamin Wu, Chao Deng, Jianjun Tan, Huawen Liu & Li Zhong. (2021) Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection. Aging 13:2, pages 1620-1632.
Crossref
Crossref
Xiaojun WangHuiyun ZhangLiangfen ZhouHui OuHengyu Liu. (2020) Efficacy and Safety of 8 spheres Plus Cisplatin Versus Vinorelbine Plus Cisplatin in Locally Advanced Non-small Cell Lung Cancer. Cancer Biotherapy and Radiopharmaceuticals.
Crossref
Crossref
Yangli Liu, Ying Zhu, Lihong Bai, Fengjia Chen, Jue Wang & Yubiao Guo. (2020) Adenocarcinomatous-predominant subtype associated with a better prognosis in adenosquamous lung carcinoma. BMC Cancer 20:1.
Crossref
Crossref
Arthur Krause, Luca Roma, Thomas Lorber, James Habicht, Didier Lardinois, Maria Rosaria De Filippo, Spasenija Savic Prince, Salvatore Piscuoglio, CharlotteKY Ng & Lukas Bubendorf. (2020) Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing. Lung Cancer 150, pages 132-138.
Crossref
Crossref
Yiming Zhao, Yu Dong, Ruiying Zhao, Bo Zhang, Shuyuan Wang, Lele Zhang, Minjuan Hu, Qingnan He, Wei Zhang & Baohui Han. (2020) Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non–small-cell Lung Cancer in China. Clinical Lung Cancer 21:5, pages e355-e362.
Crossref
Crossref
Coral García-Fernández, Cristina Fornaguera & Salvador Borrós. (2020) Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy. Cancers 12:6, pages 1609.
Crossref
Crossref
Abdulaziz B. Hamid & Ruben C. Petreaca. (2020) Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells. Cancers 12:4, pages 927.
Crossref
Crossref
G. Lin, C. Li, P.S. Li, W.Z. Fang, H.P. Xu, Y.H. Gong, Z.F. Zhu, Y. Hu, W.H. Liang, Q. Chu, W.Z. Zhong, L. Wu, H.J. Wang, Z.J. Wang, Z.M. Li, J. Lin, Y.F. Guan, X.F. Xia, X. Yi, Q. Miao, B. Wu, K. Jiang, X.B. Zheng, W.F. Zhu, X.L. Zheng, P.S. Huang, W.J. Xiao, D. Hu, L.F. Zhang, X.R. Fan, T.S.K. Mok & C. Huang. (2020) Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma. Annals of Oncology 31:4, pages 517-524.
Crossref
Crossref
Onur CEYLAN & Sevilay ÖZMEN. (2020) Trends in lung cancer incidence within the last 10 years: An Eastern Anatolian single center experience. Journal of Surgery and Medicine.
Crossref
Crossref
Sarah Glaze, Qiuli Duan, Aylin Sar, Sandra Lee, Martin Köbel, Elena Park & Máire A. Duggan. (2019) FIGO Stage Is the Strongest Prognostic Factor in Adenocarcinoma of the Uterine Cervix. Journal of Obstetrics and Gynaecology Canada 41:9, pages 1318-1324.
Crossref
Crossref
Meng-Hsiung Hsieh, Joshua H. Choe, Jashkaran Gadhvi, Yoon Jung Kim, Marcus A. Arguez, Madison Palmer, Haleigh Gerold, Chance Nowak, Hung Do, Simbarashe Mazambani, Jordan K. Knighton, Matthew Cha, Justin Goodwin, Min Kyu Kang, Ji Yun Jeong, Shin Yup Lee, Brandon Faubert, Zhenyu Xuan, E. Dale Abel, Claudio Scafoglio, David B. Shackelford, John D. Minna, Pankaj K. Singh, Vladimir Shulaev, Leonidas Bleris, Kenneth Hoyt, James Kim, Masahiro Inoue, Ralph J. DeBerardinis, Tae Hoon Kim & Jung-whan Kim. (2019) p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas. Cell Reports 28:7, pages 1860-1878.e9.
Crossref
Crossref
Afreen Idris Shariff, Sohail Syed, Rebecca A Shelby, Jeremy Force, Jeffrey Melson Clarke, David D’Alessio & Leonor Corsino. (2019) Novel cancer therapies and their association with diabetes. Journal of Molecular Endocrinology 62:2, pages R187-R199.
Crossref
Crossref
Michael C. Montalto & Robin Edwards. (2019) And They Said It Couldn't Be Done: Predicting Known Driver Mutations From H&E Slides. Journal of Pathology Informatics 10:1, pages 17.
Crossref
Crossref
Bruno Di Muzio & Yuranga Weerakkody. 2005. Radiopaedia.org. Radiopaedia.org.
Atanu Bhattacharjee, Jishu Dey & Pragya Student Kumari. (2022) Identification and Validation of Prognosis Markers for Adenocarcinoma Lung Cancer. SSRN Electronic Journal.
Crossref
Crossref